Antiandrogens
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 18, 2000
Issued Date -
N/A
app pub date -
Jun 7, 1995
filing date -
May 21, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Androgen nucleus derivatives having specified substituents at the 17.alpha. position are disclosed for use as antiandrogens for the treatment of androgen-dependent diseases. In some preferred embodiments, the compound ##STR1## is formulated together with pharmaceutically acceptable diluent or carrier for topical use in the treatment of androgen-dependent diseases associated with the skin.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully